PRIME MEDICINE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.14 USD | +1.42% |
|
+27.09% | -19.53% |
| 12:25pm | North American Morning Briefing : The "Everything -2- | DJ |
| 05-16 | Citigroup Upgrades Prime Medicine at Buy From Neutral With $10 Price Target | MT |
Chart calendar Prime Medicine, Inc.
aaf09249e5e81bec4d41.Uyrlaot2RaraO-ZNq3nmBglMAE8Nx62s6wyNRyuCLmA.Y3qGAslPLei9drY84TLSQl54bhZm9NXHnkjvNma1ZyEpep1b7y5w4Ih5ow~3f5644e6f9ac86adbf609edb6f8f3e01
Upcoming events on Prime Medicine, Inc.
Past events on Prime Medicine, Inc.
| 2024-05-16 10:45 | TIDES USA Oligonucleotide & Peptide Therapeutics Conference |
| 2024-05-14 16:15 | TIDES USA Oligonucleotide & Peptide Therapeutics Conference |
| 2024-05-10 14:45 | American Society of Gene & Cell Therapy Meeting |
| 2024-05-10 08:00 | Q1 2024 Earnings Release |
| 2024-05-08 17:15 | American Society of Gene & Cell Therapy Meeting |
| 2024-05-08 15:45 | American Society of Gene & Cell Therapy Meeting |
| 2024-05-08 12:00 | American Society of Gene & Cell Therapy Meeting |
| 2024-05-08 11:30 | Milken Institute Global Conference |
| 2024-05-07 09:45 | American Society of Gene & Cell Therapy Meeting |
| 2024-05-01 14:00 | LNP Formulation and Process Development Summit |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-03-06 12:50 | TD Cowen Health Care Conference |
| 2024-03-01 08:00 | Q4 2023 Earnings Release |
| 2024-02-08 14:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-08 17:15 | JPMorgan Healthcare Conference |
| 2023-11-28 | CRISPR Congress |
| 2023-11-16 08:30 | Jefferies London Healthcare Conference |
| 2023-11-14 16:10 | Stifel Healthcare Conference |
| 2023-11-03 | North American Cystic Fibrosis Conference |
| 2023-11-03 16:01 | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 2,00 - | 0,00 0,00 - | 5,14 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -114 -120 4.57% | -204 -179 -13.4% | -202 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -117 -112 -4.27% | -205 -185 -10.62% | -203 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -166 | -123 -110 -11.61% | -198 -182 -8.85% | -192 |
|
Net income Million USD | Released Forecast Spread | -165 | -142 -109 -30.29% | -198 -182 -9.03% | -193 |
|
EPS USD | Released Forecast Spread | 0,00 | -4,19 -1,76 -138.07% | -2,18 -1,94 -12.3% | -1,68 |
| Announcement Date | 07/03/22 | 09/03/23 | 01/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,00 - | 0,00 0,00 - | 0,59 0,91 -35.23% | 1,63 | 0,37 | 0,41 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -39,0 -39,0 0.05% | -63,4 -46,6 -35.9% | -47,0 -47,1 0.11% | -48,0 | -48,5 | -48,9 | ||||||
|
EBIT Million USD | Released Forecast Spread | -31,7 -26,3 -20.33% | -38,7 -29,4 -31.75% | -40,0 -39,3 -1.8% | -45,3 -41,5 -9.05% | -51,5 -41,4 -24.42% | -68,0 -51,2 -32.87% | -48,3 -54,1 10.61% | -49,5 | -51,0 | -52,7 | -62,1 | -51,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -39,5 -28,0 -40.96% | -39,6 -38,9 -1.8% | -42,4 -41,4 -2.36% | -50,8 -43,9 -15.85% | -65,6 -49,5 -32.73% | -45,6 -53,3 14.38% | -48,0 | -49,0 | -49,8 | -50,6 | -51,0 | |
|
Net income Million USD | Released Forecast Spread | -40,6 -28,0 -44.99% | -39,4 -38,4 -2.61% | -42,4 -41,2 -2.81% | -50,7 -43,7 -16% | -65,6 -49,4 -33% | -45,8 -54,2 15.54% | -48,0 | -49,0 | -49,8 | -50,6 | -51,0 | |
|
EPS USD | Released Forecast Spread | -1,61 -0,31 -412.45% | -0,31 | -0,44 -0,44 -0.6% | -0,47 -0,43 -8.26% | -0,55 -0,48 -15.59% | -0,72 -0,52 -38.37% | -0,44 -0,47 7.23% | -0,41 | -0,41 | -0,41 | -0,39 | -0,39 |
| Announcement Date | 14/11/22 | 09/03/23 | 11/05/23 | 07/08/23 | 03/11/23 | 01/03/24 | 10/05/24 | - | - | - | - | - |
More events
Past sector events for Prime Medicine, Inc.
| Today 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 16:01 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRME Stock
- Calendar Prime Medicine, Inc.
